Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Wall Street
Price Targets
Price Targets Summary
Sichuan Kelun Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Sichuan Kelun Pharmaceutical Co Ltd is 41.02 CNY with a low forecast of 35.35 CNY and a high forecast of 46.73 CNY.
Price Targets
Revenue
Forecast
Revenue Estimate
Sichuan Kelun Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 12%.
Operating Income
Forecast
Operating Income Estimate
Sichuan Kelun Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's operating income is 8%. The projected CAGR for the next 3 years is 13%.
Net Income
Forecast
Net Income Estimate
Sichuan Kelun Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 21%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sichuan Kelun Pharmaceutical Co Ltd's stock price target?
Price Target
41.02
CNY
According to Wall Street analysts, the average 1-year price target for Sichuan Kelun Pharmaceutical Co Ltd is 41.02 CNY with a low forecast of 35.35 CNY and a high forecast of 46.73 CNY.
What is Sichuan Kelun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 12%.
What is Sichuan Kelun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
13%
For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's operating income is 8%. The projected CAGR for the next 3 years is 13%.
What is Sichuan Kelun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 8 years the compound annual growth rate for Sichuan Kelun Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 21%.